ROTEM sigma Thromboelastometry System

FDA 510(k) K201440 · Tem Innovations GmbH

Substantially Equivalent

510(k) numberK201440

Submission

Device name
ROTEM sigma Thromboelastometry System
Applicant
Tem Innovations GmbH
Munich, DE
Received
June 1, 2020
Decision date
July 8, 2022
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
JPA – System, Multipurpose For In Vitro Coagulation Studies
Device class
Class II (moderate risk)
Regulation
21 CFR 864.5425
Specialty
Hematology

Other 510(k)s with product code JPA

510(k)DeviceApplicantDecision
K253658STA Satellite Max®JPA · Traditional Diagnostica Stago, Inc.04/27/2026SE
K250965Automated Blood Coagulation Analyzer CN-Series (CN-6000)JPA · Traditional Sysmex America, Inc.06/02/2025SE
K251024TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay CartridgeJPA · Special Haemonetics04/30/2025SE
K243858TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay CartridgeJPA · Special Haemonetics Corporation01/15/2025SE
K232018Citrated: K, KH, RTH, FFHJPA · Traditional Haemonetics Corporation03/29/2024SE
K233790Acl Top 970 CLJPA · Special Instrumentation Laboratory12/29/2023SE
K221359ACL TOP 970 CL, HemosIL CL Anti-Cardiolipin IgM, HemosIL CL Anti-ß2 Glycoprotein-I IgMJPA · Traditional Instrumentation Laboratory CO09/29/2023SE
K212183STA R Max 3, STA Compact Max 3JPA · Traditional Diagnostica Stago S.A.S06/07/2023SE
K202101GEM Hemochron 100 System, GEM Hemochron 100 Activated Clotting Time Plus Test (ACT+)…JPA · Traditional Accriva Diagnostics, Inc.12/29/2021SE
K193041Hemochron Signature EliteJPA · Special Accriva Diagnostics, Inc.11/22/2019SE

More from Accriva Diagnostics, Inc.

510(k)DeviceDecision
K101533Ex-Tem. Fib-Tem, and Ap-Tem for Rotem Delta Thromboelastometry SystemJPA · Traditional 08/10/2011SE

Questions and answers

When was ROTEM sigma Thromboelastometry System cleared by the FDA?

ROTEM sigma Thromboelastometry System (K201440) received a 510(k) decision of Substantially Equivalent on July 8, 2022, 767 days after the submission was received.

What is the product code of K201440?

The FDA product code is JPA – System, Multipurpose For In Vitro Coagulation Studies, a Class II (moderate risk) device regulated under 21 CFR 864.5425.